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Summary
Clinical and experimental studies show that aging exacerbates
hypertension-induced cerebral microhemorrhages (CMHs), which
progressively impair neuronal function. There is growing evi-
dence that aging promotes insulin-like growth factor 1 (IGF-1)
deficiency, which compromises multiple aspects of cerebromi-
crovascular and brain health. To determine the role of IGF-1
deficiency in the pathogenesis of CMHs, we induced hyperten-
sion in mice with liver-specific knockdown of IGF-1 (Igf1f/f + TBG-
Cre-AAV8) and control mice by angiotensin II plus L-NAME
treatment. In IGF-1-deficient mice, the same level of hypertension
led to significantly earlier onset and increased incidence and
neurological consequences of CMHs, as compared to control
mice, as shown by neurological examination, gait analysis, and
histological assessment of CMHs in serial brain sections. Previous
studies showed that in aging, increased oxidative stress-
mediated matrix metalloprotease (MMP) activation importantly
contributes to the pathogenesis of CMHs. Thus, it is significant
that hypertension-induced cerebrovascular oxidative stress and
MMP activation were increased in IGF-1-deficient mice. We found
that IGF-1 deficiency impaired hypertension-induced adaptive
media hypertrophy and extracellular matrix remodeling, which
together with the increased MMP activation likely also con-
tributes to increased fragility of intracerebral arterioles. Collec-
tively, IGF-1 deficiency promotes the pathogenesis of CMHs,
mimicking the aging phenotype, which likely contribute to its
deleterious effect on cognitive function. Therapeutic strategies
that upregulate IGF-1 signaling in the cerebral vessels and/or
reduce microvascular oxidative stress, and MMP activation may
be useful for the prevention of CMHs, protecting cognitive
function in high-risk elderly patients.
Key words: arteriole; dementia; gait dysfunction; microb-
leed; oxidative stress.
Introduction
Recent advances in magnetic resonance imaging techniques (e.g., T2*
gradient recall echo and Susceptibility-Weighted Imaging MRI
sequences) have allowed the detection of previously undetectable small
intracerebral hemorrhages, termed cerebral microhemorrhages (CMHs),
in elderly patients. CMHs are typically regarded as small (<5 mm)
vascular lesions associated with rupture of small intracerebral vessels and
are considered of emerging importance as a contributing factor to the
progressive impairment of neuronal function in aging (Poels et al. 2012;
Akoudad et al. 2016). Clinical and experimental evidence confirm that
the presence of CMHs is associated with decreases in processing speed
and cognitive function (Poels et al. 2012; Akoudad et al. 2016), and
manifestation of gait disturbances (de Laat et al. 2011; Choi et al. 2012;
Toth et al. 2015b).
Epidemiological studies determined that aging and hypertension are
the main risk factors for the development of cerebral microhemorrhages
(CMHs) (Poels et al., 2011). Accordingly, the prevalence of CMHs
significantly increases with age, from ~6.5% in persons aged 45 to
50 years to ~35 to 50% or more in elderly patients (Poels et al., 2011). In
the Rotterdam Scan Study (Poels et al., 2011) in elderly patients,
hypertension was a particularly strong risk factor for CMHs with a hazard
ratio of 1.66. Other studies reached the same conclusion, reporting 56%
prevalence for CMHs in elderly hypertensive subjects (Kato et al., 2002).
Recent data from animal models extend the clinical findings, demonstrat-
ing that aging and hypertension synergistically interact to exacerbate the
development of CMHs (Toth et al., 2015b). Our current understanding,
based on experimental data, is that aging promotes the development of
CMHs by exacerbating hypertension-induced oxidative stress and redox-
sensitive activation of matrix metalloproteases (MMPs) compromising the
structural integrity of the cerebral microvasculature (Toth et al., 2015b).
Yet, the specific age-related mechanism(s) that underlie the increased
susceptibility of the aged cerebral vasculature to rupture remain elusive.
Work from our laboratories and others adds to the rapidly growing
body of knowledge regarding the crucial role of endocrine mechanisms
in age-related cerebromicrovascular pathology. Particularly, the dramatic
age-related decline in circulating levels of insulin-like growth factor 1
(IGF-1) has been implicated in microvascular aging and cognitive decline
(reviewed recently in Sonntag et al., 2013). IGF-1 is a pleiotropic growth
factor that possesses multifaceted vasoprotective effects. Epidemiolog-
ical evidence suggests that low IGF-1 levels increase the risk for
cerebromicrovascular diseases (Sonntag et al., 2013). Previous research
demonstrated that rodent models with decreases of circulating IGF-1
levels also exhibit aging-like vascular phenotypes including cerebromi-
crovascular autoregulatory dysfunction, manifestation of intracerebral
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hemorrhages, neurovascular uncoupling, increased vascular oxidative
stress, dysregulation of genes encoding the ECM, and impaired
functional adaptation of cerebral arteries to hypertension (Bailey-Downs
et al., 2012; Sonntag et al., 2013; Toth et al., 2014, 2015a; Tarantini
et al., 2016a,b). Despite these advances, the pathophysiological link
between age-related circulating IGF-1 deficiency and the development
of CMHs has never been studied.
This study was designed to test the hypothesis that circulating IGF-1
deficiency promotes the development of CMHs, by exacerbating
hypertension-induced vascular oxidative stress and MMP activation
and/or by impairing microvascular structural adaptation to hypertension.
To test our hypothesis, we used a novel mouse model of isolated
endocrine IGF-1 deficiency induced by adeno-associated viral knock-
down of IGF-1 specifically in the mouse liver using Cre-lox technology
(Igf1f/f + TBG-Cre-AAV8; Toth et al., 2014, 2015a; Tarantini et al.,
2016a,b). We induced hypertension in IGF-1-deficient mice and respec-
tive controls (by treatment with angiotensin II [Ang II] and the NO
synthesis inhibitor L-NAME) and compared the incidence, size, and
localization of CMHs. To elucidate the mechanisms contributing to the
changes in CMH incidence, hypertension-induced vascular ROS produc-
tion and MMP activation were assessed and hypertension-induced
microvascular remodeling and its molecular signature were quantified.
Results
Aging exacerbates hypertension-induced spontaneous CMHs
in mice
Mice receiving TBG-Cre-AAV8 had significantly lower serum IGF-1 levels
compared with control mice receiving TBG-eGFP-AAV8 (Fig. 1A).
Treatment with Ang II plus L-NAME resulted in comparable increases in
blood pressure both IGF-1-deficient mice and their age-matched controls
(Fig. 1B). We found that during the experimental period, 56% of control
mice showed clinically manifest signs of hypertension-induced intrac-
erebral hemorrhage, as assessed by neurological examination. In
contrast, 87% of IGF-1-deficient mice developed signs of hyperten-
sion-induced intracerebral hemorrhage (Fig. 1C), which occurred within
a similar time window (the maximum difference between the cumulative
distribution curves for time-to-event in the two groups, D, is as follows:
0.2063; P = 0.753). Histological analysis confirmed that all mice with
neurological signs developed multiple CMHs that were distributed widely
in the brain (Fig. 1D–G). When the cerebral vessels associated with the
CMHs were clearly distinguishable, their internal diameter was found to
be in the range of ~10–20 lm (Fig. 1H–K). We noticed that the
hemorrhages were often confined to and spread along the perivascular
spaces (Fig. 1H–K). No normotensive mice developed neurological signs
or histologically detectable CMHs (data not shown). In hypertensive IGF-
1-deficient mice, a higher count of CMHs was observed compared to
hypertensive mice with unaltered IGF-1 levels (Fig. 1L). As shown in
Fig. 1(M), IGF-1 deficiency predominantly increased the incidence of
CMHs located in the cortex, basal ganglia, brain stem, and white matter.
Analysis of the volume distribution of CMHs (Fig. 1N) suggests that IGF-1
deficiency significantly increases the incidence of the smallest hemor-
rhages, which originate from the distal portion of the microcirculation.
Increased incidence of CMHs is associated with early gait
dysfunction in IGF-1-deficient mice
As in humans CMHs are associated with gait dysfunction (Choi et al.,
2012), we analyzed mouse gait. We found that gait abnormalities
(including a significant decline in regularity index, speed, and stride
length; Fig. 2A–C, respectively) were significantly more severe in
hypertensive IGF-1-deficient mice as compared to hypertensive control
mice, suggesting that analysis of motor function status (e.g., deficit in
interlimb coordination, temporal asymmetry) can predict the severity of
CMH burden (Toth et al., 2015b). Hypertension-induced changes in base
of support did not correlate with IGF-1 status (Fig. 2D). Phase dispersion
tended to change more in hypertensive IGF-1-deficient mice as
compared to hypertensive controls, but the difference did not reach
statistical significance (Fig. 2E). Gait parameters in normotensive IGF-1-
deficient mice and age-matched control mice did not change signifi-
cantly during the experimental period (data not shown).
IGF-1 deficiency exacerbates hypertension-induced MMP
activation
Hypertension-induced activation of MMPs is thought to play a central
role in the pathogenesis of CMHs (Wakisaka et al., 2010a,b; Toth et al.,
2015b). To determine how interaction of IGF-1 deficiency and hyper-
tension affect vascular MMP activity, MMPsense 645 FAST substrate was
administered in vivo and vascular MMP activation was compared
between hypertensive IGF-1-deficient mice and hypertensive age-
matched controls by measuring MMPsense fluorescence in brain
homogenates. Figure 3(A) shows that the brains of hypertensive IGF-1-
deficient mice exhibit significantly greater MMP activity compared to
those of the normotensive counterparts. Mice with normal IGF-1 levels
did not show a significant hypertension-induced increase in MMP
activity. In control mice, MMP activity (indicated by the presence of the
fluorescent product of the MMPsense 645 FAST substrate) was barely
detectable by confocal microscopy and was not increased significantly by
hypertension. The representative image, shown in Fig. 3(B), illustrates
that in IGF-1-deficient mice, hypertension was associated with strong
MMPsense 645 FAST fluorescence (indicating MMP activation) localized
mainly to the media of small intracerebral arteries (identified by the
intraluminal FITC–dextran fluorescence). No significant MMP 645 FAST
fluorescence was observed in the brain parenchyma in any of the groups.
Collectively, these findings suggest that IGF-1 deficiency exacerbates
hypertension-induced vascular MMP activation.
Results of previous experimental studies by our laboratories (Toth
et al., 2015b), and by others (Wakisaka et al., 2010a,b), identify
oxidative stress as a critical factor contributing to hypertension-induced
MMP activation and pathogenesis of CMHs and demonstrate that high
intraluminal pressure per se (via increased wall tension-dependent
cellular stretch) is a key stimulus for increased vascular production of ROS
(Ungvari et al., 2003; Springo et al., 2015; Toth et al., 2015b) that lead
to MMP activation. To elucidate the likely mechanism contributing to the
exacerbation of hypertension-induced MMP activation in IGF-1 defi-
ciency, we compared pressure-induced production of O2 in cerebral
arteries isolated from IGF-1-deficient mice and their respective age-
matched controls using the redox-sensitive dye dihydroethidium (DHE).
We found that nuclear DHE fluorescence was significantly stronger in
arteries of IGF-1-deficient mice that were exposed to high pressure as
compared to vessels of control mice exposed to the same pressure or
vessels of the same IGF-1-deficient animals that were exposed to
60 mmHg (Fig. 3E,F). The findings that IGF-1 deficiency exacerbates
high-pressure increases in O2 generation in the cerebral arteries are
significant as high-pressure-induced vascular MMP activation can be
inhibited by antioxidant treatments (Toth et al., 2015b).
We also detected and analyzed the mRNA expression of MMPs
and the tissue inhibitor of metalloproteinases (TIMPs; Fig. 3G–J).
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Fig. 1 IGF-1 deficiency exacerbates hypertension (HT)-induced CMHs in mice. (A) Adeno-associated viral knockdown of hepatic Ifg1 (Igf1f/f + TBG-Cre-AAV8) significantly
decreases the levels of circulating IGF-1 compared to control animals. Data are mean  SEM. *P = 0.001 vs. control (t-test). (B) Treatment with angiotensin II plus L-NAME
elicited similar increases in systolic blood pressure in control and IGF-1-deficient mice. *P < 0.05 vs. control normotensive (one-way ANOVA, Tukey’s post hoc test). (C)
Cumulative incidence curves for neurological signs of hypertension-induced intracerebral hemorrhage in control (n = 24) and IGF-1-deficient mice (n = 31). In IGF-1-
deficient mice, there was a significant increase in CMH incidence compared to control mice (log-rank test; Mantel-Cox). (D–G) Representative images of CMHs stained by
diaminobenzidine in the cortex, brain stem, white matter, and cerebellum of hypertensive IGF-1-deficient mice. (H–K) Black arrows point to cerebral intraparenchymal
arterioles in close proximity to the hemorrhages. Hemorrhages were often confined to and spread along the perivascular spaces (arrowheads). Note in (K) the spread of the
hemorrhage to the daughter branches of an arteriole along the perivascular spaces. (L): Total number of hypertension-induced CMHs throughout the entire brain of control
and IGF-1-deficient mice. Data are mean  SEM. *P < 0.05 (t-test). (M) The pie charts illustrate the similar distribution of CMHs by location in both experimental groups. (N)
The cumulative frequency distribution of CMHs by volume significantly shifts to the left in IGF-1-deficient mice compared to control, indicating that IGF-1 deficiency
specifically increases the number of smaller bleeds. The maximum difference between the cumulative distributions was calculated using the two-sample Kolmogorov–
Smirnov test (D: 0.5202; P < 0.0001).
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We found that the expression of Mmp2, Mmp3 but not Mmp9
increased significantly in the brains of hypertensive IGF-1-deficient
mice when compared to their normotensive counterpart. The
expression of Timp1, Timp2, and Timp3 consistently increased in
response to hypertension in all experimental groups, except Timp2
mRNA expression did not reach significance in hypertensive IGF-1-
deficient animals when compared to their normotensive counter-
part.
Fig. 2 Increased incidence of CMHs is associated with gait dysfunction in hypertensive IGF-1-deficient mice. Regularity index (A), body speed (B), stride length (C), and base
of support (front paws; D) in control mice and IGF-1-deficient mice under baseline conditions and after induction of CMHs. (E) Circular scatter plot showing the distribution
of interlimb coupling values (phase dispersion) in control mice and IGF-1-deficient mice under baseline conditions and after induction of CMHs (note that the circular plot
shows a smaller phase dispersion scatter in the inner circle [before hypertension] as compared to the phase dispersion scatter in the outer circle [assessed after hypertension]).
Right panels shows average deviation of phase dispersion (calculated between the right hind paw [RH] and left hind paw [LH]) from the expected value (50%) under baseline
conditions and after induction of CMHs. Data are mean  SEM.*P < 0.05 vs. control baseline, &P < 0.05 vs. IGF-1-deficient baseline, #P < 0.05 control vs. IGF-1 deficient
(one-way ANOVA, Tukey’s post hoc test) HT: hypertension.
Fig. 3 IGF-1 deficiency exacerbates hypertension-induced MMP activation. (A) Hypertension-induced MMP activation, assessed using the MMPsense 645 FAST fluorescent
method, in control and IGF-1-deficient mice (n = 6 in each group; see Experimental procedures). MMPsense 645 FAST becomes fluorescent upon cleavage by activated
MMPs. Data are mean  SEM. *P < 0.05 vs. control, #P < 0.05 vs. control HT, &P < 0.05 vs. IGF-1 deficient. (B) Representative confocal image of the longitudinal section of
a cerebral intraparenchymal arteriole from a hypertensive IGF-1-deficient mouse injected with the MMPsense 645 FAST substrate (scale bar: 25 lm). Note, the strong red
fluorescence in the vascular wall indicating increased MMP activity. Intraluminal FITC–dextran is shown for orientation purposes. L (lumen), M (media). (C): Representative
compressed Z stacks of confocal images of MCAs showing stronger MMPsense 645 FAST fluorescence (red) in high-pressure-exposed MCAs isolated from IGF-1-deficient
mice as compared to MCAs isolated from control mice, indicating increased MMP activation. MCAs were pressurized at 60 and 160 mmHg for 6 h. (original magnification:
209, scale bar: 100 lm). Bar graphs (D) are summary data. Data are means  SEM (n = 6 in each group) *P < 0.05 vs. control (60 mmHg), #P < 0.05 vs. IGF-1 deficient
(160 mmHg); &P < 0.05 vs. IGF-1 deficient (60 mmHg). (E) IGF-1 deficiency exacerbates hypertension-induced oxidative stress. Representative confocal images showing
stronger DHE fluorescence (pseudocolored white) indicating increased O2 production in high-pressure-exposed MCAs isolated from aged mice as compared to MCAs
isolated from young mice. MCAs were pressurized at 60 and 160 mmHg for 6 h. (original magnification: 209, scale bar: 50 lm). Bar graphs (F) are summary data. Data are
means  SEM (n = 6 in each group). *P < 0.05 vs. control, #P < 0.05 vs. control HT, &P < 0.05 vs. IGF-1 deficient. G–J show hypertension-induced changes in mRNA
expression of MMP-2, -3, and -9 as well as Timp-1, -2, and -3 in the cerebral arteries. Data are mean  SEM (n = 6 in each group). *P < 0.05 vs. control, &P < 0.05 vs. IGF-1
deficient. Differences between different groups were established using a one-way ANOVA followed by Tukey’s post hoc tests.
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IGF-1 deficiency impairs structural adaptation of cerebral
arterioles to hypertension
Media hypertrophy and extracellular matrix remodeling are adaptive
processes that reduce tensile stress, protecting the integrity of the
vascular wall in hypertension. We found that penetrating arterioles of
control mice exhibited structural adaptation to high pressure (mani-
fested as a significant increase in wall-to-lumen ratios; Fig. 4A), which
was associated with upregulated vascular expression of alpha smooth
muscle actin and components of the ECM (Fig. 4B,C). In contrast,
histological and molecular signs of protective structural adaptation of
cerebral vessels were not evident in hypertensive IGF-1-deficient mice
(Fig. 4A–C).
IGF-1 deficiency exacerbates hypertension-induced
profragility shift in vascular gene expression signature
Expression of genes related to the pathogenesis of CMHs was
determined by qPCR; 67 genes analyzed (Table S1) were manually
annotated as being provascular fragility and antifragility, and this data
were converted into a binary vector (1 for profragility genes and 1 for
antifragility genes). qPCR data were normalized using quantile normal-
ization, and then, for each sample, the binary fragility vector was
compared to negative normalized Ct values using Spearman’s rank
correlation coefficient (Spearman’s q) as reported (Tarantini et al.,
2016b). This ‘vascular fragility signature’, therefore, measures the
combined expression levels of positive and negative regulators of
vascular fragility: a higher value indicates higher expression of
profragility genes and lower expression of antifragility genes. We found
that IGF-1 deficiency exacerbates hypertension-induced profragility shift
in vascular gene expression signature (Fig. 4D).
Discussion
This is the first study to demonstrate that the effects of IGF-1 deficiency
phenocopies important aspects of age-related CMHs (Toth et al.,
2015b). Similar to the aging phenotype, in IGF-1 deficiency, the same
level of hypertension leads to significantly increased incidence of CMHs.
In human patients, hypertension also almost exclusively increases CMHs
at an old age (Romero et al., 2014). We found that similar to aging, IGF-
1 deficiency predominantly increases the incidence of small cerebral
hemorrhages in a cortical/subcortical location, suggesting that they both
render the same small cerebral vessels significantly more vulnerable to
high-pressure-induced rupture.
Circulating IGF-1 levels significantly decline with age (reviewed in
Sonntag et al., 2013). Our findings underscore the likely pathogenic role
of age-related IGF-1 deficiency in increased CMHs in elderly patients.
Indeed, there are many similarities between CMHs observed in IGF-1-
deficient mice and hypertensive elderly human patients, including the
relative size of the bleedings, the clinical symptoms, and the progressive
nature of the pathological process (Lee et al., 2011).
Clinical studies show that CMHs are an important mechanism for
cognitive impairment (Seo et al., 2007), and their increased prevalence
and incidence in aging are consistent with the documented age-related
exacerbation of hypertension-induced cognitive decline in humans and
laboratory animals. CMHs have also been shown to be associated with
gait dysfunction both in humans (Choi et al., 2012) and experimental
animals. Importantly, we also revealed that increased incidence of CMHs
leads to progressive gait abnormalities in IGF-1-deficient mice mimicking
the phenotype observed in hypertensive aged mice (Toth et al., 2015b).
Gait is a complex motor behavior which involves several brain regions
that coordinate to produce locomotion. Of the aforementioned studies,
the view emerges that gait abnormalities are sensitive indicators of
CMHs as lesions affecting any brain region important for gait coordi-
nation (e.g., multiple cortical areas, basal ganglia, cerebellum, and white
matter) will elicit quantifiable symptoms. The causal link between CMHs
and gait abnormalities is clinically potentially significant as gait impair-
ments are a major risk factor for falls in the elderly. Further, increasing
clinical evidence shows that gait and cognition are interrelated in older
adults (Montero-Odasso et al., 2012).
The IGF-1-dependent mechanisms responsible for increased suscep-
tibility of the cerebral circulation to hypertension-induced injury are likely
multifaceted. Previous studies suggest a central role for age-related
exacerbation of hypertension-induced cerebrovascular ROS production
and redox-sensitive activation of MMPs in the pathogenesis of CMHs
(Toth et al., 2015b), which degrade components of the basal lamina and
extracellular matrix, weakening the vascular wall. Our findings suggest
that IGF-1 deficiency itself can exacerbate hypertension-induced cere-
brovascular MMP activation, mimicking the aging phenotype, which
likely importantly contribute to the increased fragility of cerebral arteries.
While IGF-1 deficiency does not appear to be associated with marked
changes in MMP expression, it was found to exacerbate hypertension-
induced oxidative stress in cerebral arteries, presenting redox-sensitive
MMP activation (Wakisaka et al., 2010a) as a potential mechanism
responsible for the observed phenotype. This concept is supported by
recent findings showing that age-related exacerbation of hypertension-
induced MMP activation can be abolished by antioxidative treatments
(Toth et al., 2015b). Increased hypertension-induced oxidative stress in
aged arteries has been attributed to upregulation of NOX oxidases,
increased mitochondrial ROS generation, and impaired Nrf2-dependent
antioxidant defense mechanisms (Ungvari et al., 2011a,b; Springo et al.,
2015; Toth et al., 2015b). There is evidence that inhibition of ROS
synthesis by these sources can prevent development of CMHs in aging
(Toth et al., 2015b). The existing evidence suggest that circulating IGF-1
deficiency affects the same redox pathways as aging (Csiszar et al.,
2008; Bailey-Downs et al., 2012). Thus, future studies are warranted to
determine the effects of inhibitors of NOX oxidases and mitochondria-
derived ROS production on the genesis of CMHs in IGF-1 deficiency as
well. We posit that development of CMHs in the elderly and in IGF-1-
deficient patients may also be exacerbated by deficiency of NO due to its
increased breakdown by elevated levels of ROS (Toth et al., 2015a). NO
deficiency likely amplifies the effect of angiotensin II and significantly
increases the stiffness of the conduit arteries, impairing Windkessel
function, increasing pulse pressure, and promoting penetration of the
pressure wave into the cerebral microcirculation (Tarumi et al., 2014).
The mechanisms by which IGF-1 deficiency promote CMHs likely also
involve impaired structural and functional adaptation of the cerebral
circulation to hypertension. Several lines of evidence support this
concept. During hypertension, healthy cerebral arterioles undergo
structural remodeling including hypertrophy of the media (Baumbach
& Heistad, 1989), which reduce circumferential stress, preventing
mechanical damage to the vascular wall. Our findings suggest that
IGF-1 deficiency perturbs arteriolar remodeling processes by impairing
hypertension-induced adaptive media hypertrophy and extracellular
matrix remodeling. It is likely that the resulting increases in circumfer-
ential stress are causally linked to the increased susceptibility to CMHs.
High-pressure/increased wall stress itself appears to be the main stimulus
for increased vascular MMP activation, as well as ROS production
associated with IGF-1 deficiency and aging (Toth et al., 2015b). Thus, it
is likely that penetration of increased arterial pressure to the vulnerable
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Fig. 4 IGF-1 deficiency impairs hypertension-induced hypertrophy and structural remodeling in cerebral vessels. (A) Representative confocal micrographs from normotensive
(NT) and hypertensive (HT) fixed brains. Hypertension induces hypertrophy of penetrating arterioles in control mice, whereas this adaptive response is impaired in IGF-1-
deficient mice (green fluorescence: immunostaining for alpha smooth muscle actin). Bar graphs are summary data for calculated wall-to-lumen ratios. qPCR data showing
mRNA expression of alpha smooth muscle actin and collagens in branches of the middle cerebral arteries isolated from normotensive and hypertensive control and IGF-1-
deficient mice are shown in panels B and C, respectively. Data are mean  SEM (n = 4–6 in each group), *P < 0.05 vs. control, #P < 0.05 vs. control HT. (D) IGF-1 deficiency
exacerbates hypertension-induced profragility shift in vascular gene expression signature. Expression of 67 genes related to the pathogenesis of CMHs was determined by
qPCR, and vascular fragility signatures (Spearman’s q) were calculated as described in the Results. A higher ‘fragility signature’ indicates higher expression of profragility
genes and lower expression of antifragility regulators. (E) Proposed scheme depicting the mechanisms by which age-related IGF-1 deficiency may exacerbate hypertension-
induced microvascular damage, promoting CMHs. Differences between different groups were established using a one-way ANOVA followed by Tukey’s post hoc tests.
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distal portion of the cerebral microcirculation is a critical factor in the
development of CMHs. In support of this concept, previous studies
demonstrated that aging results in autoregulatory dysfunction both in
human patients and experimental animals (Toth et al., 2015b), likely
contributing the pathogenesis of CMHs. In that regard, it is significant
that IGF-1 deficiency is also associated with cerebral autoregulatory
dysfunction and impaired myogenic adaptation of the cerebral resistance
arteries to high pressure (Toth et al., 2014), which likely allows sudden
increases in blood pressure to inflict damage to the thin-walled cerebral
microvessels.
In conclusion, our results add to the growing evidence that circulating
IGF-1 exerts complex cerebromicrovascular protective effects and that
cerebromicrovascular dysfunction associated with age-related IGF-1
deficiency compromises multiple aspects of brain health (Sonntag et al.,
2013). The findings that IGF-1 deficiency promotes the pathogenesis of
CMHs by exacerbating hypertension-induced cerebrovascular oxidative
stress and MMP activation and leading to structural and functional (Toth
et al., 2014) maladaptation to hypertension (Fig. 4E) have important
clinical relevance for the pathogenesis of vascular cognitive impairment
and gait abnormalities in elderly hypertensive patients. Our findings,
taken together with the results of earlier studies (reviewed in Sonntag
et al., 2013), point to potential benefits of interventions preventing age-
related decline in circulating IGF-1 levels and promoting microvascular
health for prevention of CMHs and cognitive decline in the elderly.
Although treatment with recombinant IGF-1 in the elderly is currently
not recommended due to a potentially increased risk for cancer, other
treatment options that increase vascular IGF-1 signaling, attenuate
vascular ROS production, and/or reduce MMP activation could be
considered for cerebromicrovascular protection in older individuals at risk
for CMHs.
Experimental procedures
All procedures were approved by and followed the guidelines of the
Institutional Animal Care and Use Committee of the University of
Oklahoma HSC and are reported in accordance with the ARRIVE
guidelines.
Induction of adult-onset IGF-1 deficiency in mice
Male mice homozygous for a floxed exon 4 of the Igf1 gene (Igf1f/f; in a
C57BL/6 background) were purchased from Jackson Laboratories (Bar
Harbor, ME, USA). These mice have the entirety of exon 4 of the Igf1
gene flanked by loxP sites, which allows for genomic excision of this
exon when exposed to Cre recombinase. Transcripts of the altered Igf1
gene yield a protein upon translation that fails to bind the IGF receptor.
Adult-onset circulating IGF-1 deficiency was induced in Igf1f/f mice by
adeno-associated virus (AAV8)-mediated expression of Cre recombinase
in the liver at 4 months of age, as reported (Toth et al., 2014). The AAV8
vector was purchased from the University of Pennsylvania Viral Vector
Core (Penn Vector Core, Philadelphia, PA, USA; http://www.med.upe
nn.edu/gtp/vectorcore). Although AAV8 is effective at transducing
multiple tissues, the use of thyroxine-binding globulin (TBG) promoter
allows for the restriction of expression to hepatocytes. At 4 months of
age, Igf1f/f mice were randomly assigned to two groups and were
administered approximately 1.3 9 1010 viral particles of AAV8-TBG-Cre
or AAV8-TBG-eGFP via retro-orbital injection, as described. Circulating
IGF-1 is produced in the liver. As circulating IGF-1 levels during
adolescence play a critical role in development of many organs,
including the cardiovascular system, this mouse model was developed
to be able to selectively study the consequences of adult-onset
circulating IGF-1 deficiency (Toth et al., 2014). Animals were housed
in the Rodent Barrier Facility at OUHSC under specific pathogen-free
barrier conditions, on a 12-h light/12-h dark cycle, with access to
standard rodent chow (Purina Mills, Richmond, IN, USA) and water
ad libitum.
Measurement of serum IGF-1 levels
Submandibular venous blood was collected into microcentrifuge tubes
using a sterile lancet (Medipoint, Mineola, NY, USA) according to the
manufacturer’s instructions. Whole blood was centrifuged at 2500 g for
20 min at 4 °C to collect serum, which was then stored at 80 °C. IGF-
1 concentration in the serum samples was measured by ELISA (R&D
Systems, Minneapolis, MN, USA) as reported (Toth et al., 2014). An IGF-
1 control sample, with aliquots stored at 80 °C, was included on each
plate. Serum IGF-1 levels are reported in ng mL1.
Induction of spontaneous CMHs
To study the effects of IGF-1 deficiency on spontaneous, hypertension-
induced CMHs, we used a previously well-characterized mouse model
(Toth et al., 2015b). Briefly, in 10-month-old male IGF-1-deficient mice
(Igf1f/f + TBG-Cre-AAV, n = 60) and respective age-matched control
mice (Igf1f/f + TBG-eGFP-AAV8, n = 60), hypertension was induced by a
combination treatment with x-nitro-L-arginine-methyl ether (L-NAME,
100 mg kg1 day1, in drinking water) and administration of angioten-
sin II (Ang II; s.c. via osmotic mini-pumps [Alzet Model 2006,
0.15 lL h1, 42 days; Durect Co, Cupertino, CA, USA]). Pumps were
filled either with saline or solutions of angiotensin II (Sigma Chemical Co.,
St. Louis, MO, USA) that delivered (subcutaneously) 1 lg min1 kg1 of
angiotensin II for 28 days, thus generating four experimental groups: (1)
Igf1f/f + TBG-Cre-AAV8 + Ang II, (2) Igf1f/f + TBG-Cre-AAV8 + vehicle,
(3) Igf1f/f + TBG-eGFP-AAV8 + Ang II, and (4) Igf1f/f + TBG-eGFP-
AAV8 + vehicle. Pumps were placed into the subcutaneous space of
ketamine/xylazine anesthetized mice through a small incision in the
interscapular area that was closed with surgical sutures using aseptic
techniques. All incision sites healed rapidly without the need for
additional medication. As aging is associated with increased activity of
the vascular renin–angiotensin system and Ang II-dependent hyperten-
sion is common among older individuals, Ang II-dependent hypertension
is a clinically highly relevant model to study aging-related cerebrovascular
alterations (Toth et al., 2013).
Blood pressure of the animals was recorded before the treatment and
every second day during the treatment period using a tail-cuff blood
pressure apparatus (CODA NonInvasive Blood Pressure System; Kent
Scientific Co., Torrington, CT, USA), as described (Toth et al., 2015b).
Each experimental group was closely monitored and mice were killed
upon the occurrence of neurological signs of intracerebral hemorrhages.
For cross-sectional studies (including histology, MMP activation, molec-
ular studies), a second cohort of animals was sacrificed on day 10
postinduction of hypertension.
Standardized neurological examination of mice
To assess the occurrence of clinically manifest hemorrhages daily,
neurological examination was performed as reported (Toth et al.,
2015b), by assessing each animal’s spontaneous activity, symmetry in
the movement of the four limbs, forelimb outstretching, climbing ability,
body proprioception, response to vibrissae touch, and gait coordination.
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Each examined animal was provided with a daily score calculated by the
summation of all individual test scores. When a consistent decline in the
neurological score was observed or on day 28 of the study, mice were
euthanized by CO2 asphyxiation.
Analysis of gait function
To assess gait function and the spatial and temporal aspects of interlimb
coordination, the animals were tested using the CatWalk System (Noldus
Information Technology Inc., Leesburg, VA, USA), as reported (Toth
et al., 2015b). Briefly, animals were trained to cross the walkway and
then, in a dark room, had five consecutive volunteer runs on the day
before and on each day after induction of hypertension. CMH-related
changes in speed, base of support, interpaw phase dispersion/phase lag,
stride length, and regularity index were assessed. The regularity index
(%) is a fractional measure of interpaw coordination, which expresses
the number of normal step sequence patterns relative to the total
number of paw placements. Its value in healthy animals is ~100%. Phase
dispersion is a measure of the temporal relationship between placement
of two hind paws within a step cycle.
Histological analysis of intracerebral hemorrhages
Mice were euthanized and transcardially perfused with ice-cold hep-
arinized PBS for 5 min and subsequently decapitated as reported (Toth
et al., 2015b). Then, the brains were isolated and fixed in 10% formalin
at room temperature for one day. The next day, the brains were placed
in fresh 10% formalin (at 4 °C, for 2 days), then in 70% ethanol (at
4 °C, for 2 days), followed by embedding in paraffin. The brains were
serially sectioned at 8 lm thickness, yielding approximately 1500
sections per brain. The first two sections of every five section were
stained with hematoxylin to reveal the brain structure and diaminoben-
zidine (DAB) to highlight the presence of hemorrhages. DAB turns into
dark brown when it undergoes a reaction with peroxidases present in
red blood cells, therefore allowing precise detection of extravasated
blood cells in the parenchyma of the brain. All stained sections were
screened by a reader blinded to the treatment groups, and images were
acquired in the evidence of a positive DAB reaction. Digital images were
analyzed with IMAGEJ software (NIH) to identify the location and quantify
the number and size of hemorrhages. The volumetric reconstruction of
hemorrhages was estimated according to the following formula as
described (Toth et al., 2015b).
CMH volume ðmm3Þ ¼
Xi
n¼1
½3 (CMH area)i  (slice thickness)i :
Assessment of hypertension-induced MMP activation in the
cerebral vessels in situ
Mice from each experimental group were temporarily anesthetized with
ketamine/xylazine and injected retro-orbitally with a 100 lL dose of
40 nmol L1 MMPsense 645 FAST substrate (PerkinElmer Inc., Boston,
MA, USA; 3 lmol L1; at 37 °C, for 6 h, in the dark), as reported (Toth
et al., 2015b). This substrate is normally optically inert. Once it is
cleaved, its subunits become excitable at 649 nm and emit a red signal
that can be measured as an indicator of activity of MMP 2, 3, 7, 9, 12,
and 13. After 12 h of circulation of the substrate, animals were
transcardially perfused with ice-cold PBS containing 1 9 heparin and
FITC–dextran (to highlight the vascular lumen). Then, the mice were
decapitated and the brains were removed and cut in half. From the left
hemisphere, the frontal cortex containing the photoactive substrate was
isolated and homogenized. To quantify MMP activity, the background-
corrected fluorescence (Ex: 649 nm, Em: 666 nm) was measured
spectrophotofluorometrically using a microplate reader and normalized
to tissue weight, as described (Toth et al., 2015b). The right hemisphere
was embedded in OCT (optimum cutting temperature) media and
cryosectioned, and confocal images of brain areas containing cross
sections of penetrating small arteries were captured as described (Toth
et al., 2015b).
Detection of high-pressure-induced activation of MMPs in
isolated cerebral arteries
In separate experiments, pressure-induced MMP activity was measured
in cannulated segments of the middle cerebral arteries, as described
(Toth et al., 2015b). In brief, two segments of the middle cerebral
arteries were isolated from the brains of mice from control and IGF-1-
deficient mice. The vessels were mounted onto two glass micropipettes
in an organ chamber in oxygenated (21% O2, 5% CO2, 75% N2) Krebs’
buffer (composed of [in mmol L1]: 110.0 NaCl, 5.0 KCl, 2.5 CaCl2, 1.0
MgSO4, 1.0 KH2PO4, 5.5 glucose, and 24.0 NaHCO3, pH ~7.4; at 37 °C)
and pressurized to 10 mmHg. Inflow and outflow pressures were
controlled and measured by a pressure servo-control system (Living
Systems Instrumentation, Burlington, VE, USA). Vessels from the same
animals were pressurized to 60 or 160 mmHg (to recapitulate in vitro the
hemodynamic environment present in the vascular system during
normotension and hypertension, respectively) in the presence of
MMPsense 645 FAST substrate for 8 h. After the incubation period,
the vessels were thoroughly rinsed, placed on a glass slide, and imaged
with a Leica SP2 upright confocal microscope. The detected fluorescence
intensity emitted at 666 nm was measured, corrected for the back-
ground, and normalized to vessel surface area using the METAMORPH
software (Molecular Devices LLC, Sunnyvale, CA, USA).
Detection of high-pressure-induced production of ROS in
isolated cerebral arteries
In separate experiments, pressure-induced ROS production was mea-
sured in cannulated segments of the middle cerebral arteries, as
described (Springo et al., 2015; Toth et al., 2015b). In brief, the arteries
from each control and IGF-1-deficient mice were pressurized to 60 or
160 mmHg for 4 h. To characterize high-pressure-induced vascular ROS
production, at the end of the incubation period, the vessels were loaded
with the redox-sensitive dye DHE (Invitrogen, Carlsbad, CA, USA;
3 9 106 mol L1; for 30 min). After loading, the chamber was washed
out five times with warm Krebs buffer, and the vessels were allowed to
equilibrate for another 20 min. After the experimental period, confocal
images of the wall of the pressurized vessels were captured using a Leica
SP2 confocal laser scanning microscope (Leica Microsystems GmbH,
Wetzlar, Germany). Average nuclear DHE fluorescence intensities were
assessed using the METAMORPH software (Molecular Devices LLC, Sunny-
vale, CA, USA), and values for each animal in each group were averaged.
Assessment of hypertension-induced hypertrophy of
penetrating arterioles
To determine the effect of IGF-1 deficiency on adaptive hypertension-
induced hypertrophy of the arteriolar wall, on day 10 postinduction of
hypertension, brains were perfusion-fixed (4% ice-cold paraformalde-
hyde; at 100 mmHg). Then, frozen OCT-embedded sagittal sections
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(35 lm) were cut and stored free-floating in cryoprotectant solution
(25% glycerol, 25% ethylene glycol, 25% of 0.1 M phosphate buffer,
and 25% water) at 20 °C. Sections were rinsed with Tris-buffered
saline (TBS), permeabilized with TBS with 0.05% Tween-20. Antigen
retrieval was achieved using 10 mM citrate buffer (10 mM sodium citrate
and 0.05% Tween 20, pH 6.0) at 90 °C for 20 min followed by 1%
sodium borohydride in PBS at room temperature for 30 min. After
blocking with 5% BSA and 1% fish gelatin in TBS at room temperature
for 2 h, sections were immunostained using rabbit anti-alpha smooth
muscle actin (ab5694 1:200; Abcam, Cambridge, MA, USA) primary
antibody for 24 h at 4 °C. Sections were washed for 10 min in TBS
(three times), incubated in Alexa Fluor 488 goat anti-rabbit secondary
antibody (A11070, 1:200; Life Technologies) for 1 h at room temper-
ature, washed for 10 min (three times) in TBST, transferred to slides, and
coverslipped. Confocal images of penetrating arterioles were obtained
using Leica SP2 MP confocal laser scanning microscope. Wall-to-lumen
ratios were calculated using the Metamorph software, and values for
each animal were averaged.
Determination of expression changes in CMH-related genes
by quantitative real-time RT–PCR
To predict gene targets associated with vascular fragility and CMHs,
we used the IRIDESCENT (Wren & Garner, 2004) text mining package,
as described (Toth et al., 2015a,b). Using this method, important
genes relevant for the pathogenesis of CMHs and structural integrity
of the vasculature were identified (Table S1). The mRNA expression of
these genes in cerebral arteries isolated on day 10 post-induction of
hypertension was analyzed by a quantitative real-time RT–PCR
technique using a Strategen MX3000 platform, as previously reported
(Toth et al., 2015b). In brief, total RNA was isolated with a Mini RNA
Isolation Kit (Zymo Research, Orange, CA, USA) and was reverse-
transcribed using Superscript III RT (Invitrogen). Amplification efficien-
cies were determined using a dilution series of a standard vascular
sample. Quantification was performed using the efficiency-corrected
DDCq method. The relative quantities of the reference genes Hprt,
Ywhaz, B2m, Gapdh, Actb, and S18 were determined, and a
normalization factor was calculated based on the geometric mean
for internal normalization. Fidelity of the PCR was determined by
melting temperature analysis and visualization of the product on a 2%
agarose gel.
Statistical analysis
An a priori power analysis was performed to ensure 80% or greater
power for the primary outcome measures, considering the findings of
previous studies (Toth et al., 2015b). Cumulative incidence of signs of
hemorrhage was evaluated using a Kaplan–Meier test, and the difference
among groups was analyzed by log-rank test (Mantel-Cox). Differences
between different groups were established using a one-way ANOVA
followed by Tukey’s post hoc tests. P < 0.05 was considered significant.
Data are expressed as mean  SEM. Statistical analyses were conducted
using PRISM 5 software (GraphPad, La Jolla, CA, USA).
Acknowledgments
Portions of this work were presented and published in thesis form in
fulfillment of the requirements for the PhD for Stefano Tarantini from
the University of Oklahoma Health Sciences Center.
Funding
This work was supported by grants from the American Heart Association
(to ST, MNVA, AC and ZU), the National Center for Complementary and
Alternative Medicine (R01-AT006526 to ZU), the National Institute on
Aging (R01-AG047879; R01-AG038747; 3P30AG050911-02S1), the
National Institute of Neurological Disorders and Stroke (NINDS; R01-
NS056218 to AC), the National Heart, Lung and Blood Institute
(1R01HL132553-01), the Arkansas Claude Pepper Older Americans
Independence Center at University of Arkansas Medical Center (to ZU;
P30 AG028718), the Oklahoma Center for the Advancement of Science
and Technology (to AC, ZU), the Oklahoma IDeA Network for Biomedical
Research Excellence (to AC), the NIA-supported Geroscience Training
Program in Oklahoma (T32 AG052363-01), and the Reynolds Foundation




ST, AC, and ZU designed research; ST, MNVA, AY, NA, GF, ZS, TG
performed experiments; ST, ZS, MNVA, AC, CG, JW, WES, and ZU
analyzed and interpreted data; ST, AC, and ZU wrote and revised the
manuscript.
References
Akoudad S, Wolters FJ, Viswanathan A, de Bruijn RF, van der Lugt A,
Hofman A, Koudstaal PJ, Ikram MA, Vernooij MW (2016) Association of
cerebral microbleeds with cognitive decline and dementia. JAMA Neurol.
73, 934–943.
Bailey-Downs LC, Mitschelen M, Sosnowska D, Toth P, Pinto JT, Ballabh P, Valcarcel-
Ares MN, Farley J, Koller A, Henthorn JC, Bass C, Sonntag WE, Ungvari Z, Csiszar
A (2012) Liver-specific knockdown of IGF-1 decreases vascular oxidative stress
resistance by impairing the Nrf2-dependent antioxidant response: a novel model
of vascular aging. J. Gerontol. Biol. Med. Sci. 67, 313–329.
Baumbach GL, Heistad DD (1989) Remodeling of cerebral arterioles in chronic
hypertension. Hypertension 13, 968–972.
Choi P, Ren M, Phan TG, Callisaya M, Ly JV, Beare R, Chong W, Srikanth V (2012)
Silent infarcts and cerebral microbleeds modify the associations of white matter
lesions with gait and postural stability: population-based study. Stroke 43, 1505–
1510.
Csiszar A, Labinskyy N, Perez V, Recchia FA, Podlutsky A, Mukhopadhyay P,
Losonczy G, Pacher P, Austad SN, Bartke A, Ungvari Z (2008) Endothelial
function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf
mice. Am. J. Physiol. Heart Circ. Physiol. 295, H1882–H1894.
Kato H, Izumiyama M, Izumiyama K, Takahashi A, Itoyama Y (2002) Silent cerebral
microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke
recurrence, and leukoaraiosis. Stroke 33, 1536–1540.
de Laat KF, van den Berg HA, van Norden AG, Gons RA, Olde Rikkert MG, de
Leeuw FE (2011) Microbleeds are independently related to gait disturbances in
elderly individuals with cerebral small vessel disease. Stroke 42, 494–497.
Lee SH, Lee ST, Kim BJ, Park HK, Kim CK, Jung KH, Roh JK (2011) Dynamic
temporal change of cerebral microbleeds: long-term follow-up MRI study. PLoS
One 6, e25930.
Montero-Odasso M, Verghese J, Beauchet O, Hausdorff JM (2012) Gait and
cognition: a complementary approach to understanding brain function and the
risk of falling. J. Am. Geriatr. Soc. 60, 2127–2136.
Poels MM, Ikram MA, van der Lugt A, Hofman A, Krestin GP, Breteler MM,
Vernooij MW (2011) Incidence of cerebral microbleeds in the general popula-
tion: the Rotterdam Scan Study. Stroke 42, 656–661.
Poels MM, Ikram MA, van der Lugt A, Hofman A, Niessen WJ, Krestin GP, Breteler
MM, Vernooij MW (2012) Cerebral microbleeds are associated with worse
cognitive function: the Rotterdam Scan Study. Neurology 78, 326–333.
Cerebral microhemorrhages in IGF-1 deficiency, S. Tarantini et al.478
ª 2017 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
Romero JR, Preis SR, Beiser A, DeCarli C, Viswanathan A, Martinez-Ramirez S, Kase
CS, Wolf PA, Seshadri S (2014) Risk factors, stroke prevention treatments, and
prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke 45,
1492–1494.
Seo SW, Hwa Lee B, Kim EJ, Chin J, Sun Cho Y, Yoon U, Na DL (2007) Clinical
significance of microbleeds in subcortical vascular dementia. Stroke 38, 1949–
1951.
Sonntag WE, Deak F, Ashpole N, Toth P, Csiszar A, Freeman W, Ungvari Z (2013)
Insulin-like growth factor-1 in CNS and cerebrovascular aging. Front. Aging
Neurosci. 5, 27.
Springo Z, Tarantini S, Toth P, Tucsek Z, Koller A, Sonntag WE, Csiszar A, Ungvari Z
(2015) Aging exacerbates pressure-induced mitochondrial oxidative stress in
mouse cerebral arteries. J. Gerontol. A Biol. Sci. Med. Sci. 70, 1355–1359.
Tarantini S, Giles CB, Wren JD, Ashpole NM, Valcarcel-Ares MN, Wei JY, Sonntag
WE, Ungvari Z, Csiszar A (2016a) IGF-1 deficiency in a critical period early in life
influences the vascular aging phenotype in mice by altering miRNA-mediated
post-transcriptional gene regulation: implications for the developmental origins
of health and disease hypothesis. Age (Dordr) 38, 239–258.
Tarantini S, Tucsek Z, Valcarcel-Ares M, Toth P, Gautam T, Giles C, Ballabh P, Wei
Y, Wren J, Ashpole N, Sonntag W, Ungvari Z, Csiszar A (2016b) Circulating IGF-1
deficiency exacerbates hypertension-induced microvascular rarefaction in the
mouse hippocampus and retrosplenial cortex: implications for cerebromicrovas-
cular and brain aging. Age (Dordr) 38,273–289.
Tarumi T, Ayaz Khan M, Liu J, Tseng BY, Parker R, Riley J, Tinajero C, Zhang R
(2014) Cerebral hemodynamics in normal aging: central artery stiffness, wave
reflection, and pressure pulsatility. J. Cereb. Blood Flow Metab. 34, 971–978.
Toth P, Tucsek Z, Sosnowska D, Gautam T, Mitschelen M, Tarantini S, Deak F,
Koller A, Sonntag WE, Csiszar A, Ungvari Z (2013) Age-related autoregulatory
dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced
hypertension. J. Cereb. Blood Flow Metab. 33, 1732–1742.
Toth P, Tucsek Z, Tarantini S, Sosnowska D, Gautam T, Mitschelen M, Koller A,
Sonntag WE, Csiszar A, Ungvari Z (2014) IGF-1 deficiency impairs cerebral
myogenic autoregulation in hypertensive mice. J. Cereb. Blood Flow Metab. 34,
1887–1897.
Toth P, Tarantini S, Ashpole NM, Tucsek Z, Milne GL, Valcarcel-Ares NM, Menyhart
A, Farkas E, Sonntag WE, Csiszar A, Ungvari Z (2015a) IGF-1 deficiency impairs
neurovascular coupling in mice: implications for cerebromicrovascular aging.
Aging Cell 14, 1034–1044.
Toth P, Tarantini S, Springo Z, Tucsek Z, Gautam T, Giles CB, Wren JD, Koller A,
Sonntag WE, Csiszar A, Ungvari Z (2015b) Aging exacerbates hypertension-
induced cerebral microhemorrhages in mice: role of resveratrol treatment in
vasoprotection. Aging Cell 14, 400–408.
Ungvari Z, Csiszar A, Huang A, Kaminski PM, Wolin MS, Koller A (2003) High
pressure induces superoxide production in isolated arteries via protein kinase C-
dependent activation of NAD(P)H oxidase. Circulation 108, 1253–1258.
Ungvari Z, Bailey-Downs L, Gautam T, Sosnowska D, Wang M, Monticone RE,
Telljohann R, Pinto JT, de Cabo R, Sonntag WE, Lakatta E, Csiszar A (2011a)
Age-associated vascular oxidative stress, Nrf2 dysfunction and NF-kB activation
in the non-human primateMacaca mulatta. J. Gerontol. A Biol. Sci. Med. Sci. 66,
866–875.
Ungvari Z, Bailey-Downs L, Sosnowska D, Gautam T, Koncz P, Losonczy G, Ballabh
P, de Cabo R, Sonntag WE, Csiszar A (2011b) Vascular oxidative stress in aging:
a homeostatic failure due to dysregulation of Nrf2-mediated antioxidant
response. Am. J. Physiol. Heart Circ. Physiol. 301, H363–H372.
Wakisaka Y, Chu Y, Miller JD, Rosenberg GA, Heistad DD (2010a) Critical role for
copper/zinc-superoxide dismutase in preventing spontaneous intracerebral
hemorrhage during acute and chronic hypertension in mice. Stroke 41, 790–
797.
Wakisaka Y, Chu Y, Miller JD, Rosenberg GA, Heistad DD (2010b) Spontaneous
intracerebral hemorrhage during acute and chronic hypertension in mice. J.
Cereb. Blood Flow Metab. 30, 56–69.
Wren JD, Garner HR (2004) Shared relationship analysis: ranking set cohesion and
commonalities within a literature-derived relationship network. Bioinformatics
20, 191–198.
Supporting Information
Additional Supporting Information may be found online in the supporting
information tab for this article.
Table S1 List of important genes relevant for the structural integrity of the
vasculature and potentially the pathogenesis of CMHs whose vascular
expression was analyzed by qPCR.
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